Research News for 2011
-
Some High Blood Pressure Meds May Increase Risk of Recurrence
New research suggests that ACE inhibitors, a type of blood pressure medicine, may increase the risk of breast cancer recurrence.
-
Experts Conclude Link Between Breast Implants, Rare Lymphoma Likely
An expert panel concluded that there's likely a link between breast implants and a rare form of lymphoma, but this lymphoma can be treated successfully by removing the implant and tissue capsule.
-
Genetic Testing of Breast Milk May Help Determine Risk
A small, very early study suggests that doing genetic testing on breast milk could help identify women with breast cancer and women at high risk for breast cancer.
-
Estrogen-Only Hormone Replacement Therapy Seems to Decrease Risk
A new study suggests that postmenopausal women who take estrogen-only HRT may have a somewhat lower risk invasive breast cancer.
-
Worry About Recurrence Linked to Ethnic Background
Research shows that a woman's level of worry about breast cancer coming back is linked to her ethic background.
-
MRI Better at Detecting Cancer Earlier in Women with Abnormal Breast Cancer Gene
New research has found that women with an abnormal breast cancer gene screened with MRI were less likely to be diagnosed with advanced-stage breast cancer compared to being screened with other tests.
-
Older Women Diagnosed with DCIS or Early-Stage Disease Have Excellent Prognosis
A large study found that women older than 67 diagnosed with either DCIS or stage I breast cancer were just as likely to be alive 10 years after diagnosis as women not diagnosed with breast cancer.
-
Tamoxifen Effectively Lowers Breast Cancer Risk in High-Risk Women Younger Than 55
An analysis of four large studies found that tamoxifen effectively reduces breast cancer risk in women younger than 55 at high risk. This benefit outweighed the costs and potential side effects of treatment.
-
FDA Approves Generic Taxotere
The FDA has approved a generic form of Taxotere, which may lower treatment costs.
-
Chemo, Hormonal Therapy May Increase Risk of Falling
Research suggests that women who get chemotherapy or hormonal therapy to treat early-stage breast cancer are more likely to fall than women the same age who don't get those treatments.
